Flagship Harbor Advisors, LLC Edwards Lifesciences Corp Transaction History

Flagship Harbor Advisors, LLC

$1.52 Billion
Q1 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 11,477 shares of EW stock, worth $751,513. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,477

Previous 11,465 0.1%

Holding current value

$751,513

Previous $874,000 25.4%

% of portfolio

0.07%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$72.54 - $95.56 $870 - $1,146	12 Added 0.1%	11,477 $1.1 Million
Q4 2023 Jan 10, 2024	BUY	$61.71 - $77.76 $73,990 - $93,234	1,199 Added 11.68%	11,465 $874,000
Q3 2023 Oct 17, 2023	BUY	$69.28 - $93.38 $62,836 - $84,695	907 Added 9.69%	10,266 $711,000
Q2 2023 Jul 11, 2023	SELL	$81.41 - $94.33 $12,944 - $14,998	-159 Reduced 1.67%	9,359 $882,000
Q1 2023 Apr 12, 2023	BUY	$74.26 - $84.51 $24,580 - $27,972	331 Added 3.6%	9,518 $787,000
Q4 2022 Jan 13, 2023	BUY	$68.3 - $87.44 $92,546 - $118,481	1,355 Added 17.3%	9,187 $0
Q3 2022 Oct 13, 2022	BUY	$82.37 - $107.29 $27,593 - $35,942	335 Added 4.47%	7,832 $647,000
Q2 2022 Jul 13, 2022	SELL	$86.5 - $128.27 $12,715 - $18,855	-147 Reduced 1.92%	7,497 $713,000
Q1 2022 Apr 13, 2022	SELL	$101.96 - $128.34 $9,176 - $11,550	-90 Reduced 1.16%	7,644 $900,000
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $23,188 - $28,488	-218 Reduced 2.74%	7,734 $1 Million
Q2 2021 Jul 26, 2021	SELL	$83.84 - $104.76 $59,023 - $73,751	-704 Reduced 8.13%	7,952 $824,000
Q1 2021 May 03, 2021	BUY	$78.68 - $90.67 $37,058 - $42,705	471 Added 5.75%	8,656 $724,000
Q4 2020 Feb 08, 2021	SELL	$71.69 - $91.23 $5,089 - $6,477	-71 Reduced 0.86%	8,185 $747,000
Q3 2020 Oct 13, 2020	BUY	$67.19 - $87.44 $61,881 - $80,532	921 Added 12.56%	8,256 $658,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $295,122 - $394,676	5,129 Added 232.5%	7,335 $506,000
Q1 2020 May 12, 2020	BUY	$52.41 - $81.0 $30,712 - $47,466	586 Added 36.17%	2,206 $416,000
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $4,660 - $5,335	-65 Reduced 3.86%	1,620 $378,000
Q3 2019 Oct 22, 2019	SELL	$61.55 - $75.43 $11,325 - $13,879	-184 Reduced 9.84%	1,685 $370,000
Q2 2019 Jul 22, 2019	BUY	$55.74 - $64.41 $8,249 - $9,532	148 Added 8.6%	1,869 $345,000
Q1 2019 Apr 15, 2019	BUY	$47.89 - $64.05 $766 - $1,024	16 Added 0.94%	1,721 $329,000
Q4 2018 Jan 28, 2019	SELL	$46.41 - $56.94 $835 - $1,024	-18 Reduced 1.04%	1,705 $261,000
Q3 2018 Nov 05, 2018	BUY	$45.7 - $58.03 $228 - $290	5 Added 0.29%	1,723 $294,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $636 - $769	-15 Reduced 0.87%	1,718 $250,000
Q1 2018 Apr 24, 2018	SELL	$37.19 - $47.45 $13,946 - $17,793	-375 Reduced 17.79%	1,733 $234,000
Q4 2017 Jan 24, 2018	BUY	$33.79 - $39.39 $71,229 - $83,034	2,108	2,108 $252,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Edwards Lifesciences Corp Transaction History